PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)

  • Hildebrandt, Gerhard (PI)

Grants and Contracts Details

StatusActive
Effective start/end date2/27/2012/5/22